Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. (BDTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BDTX · as of Jun 8, 2026
Key Statistics
Explore Black Diamond Therapeutics, Inc. Data
bdtx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 90.9%
The BDTX analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $8.00, representing +332.43% upside from the current price of $1.85.
Competitors & Peers
bdtx competitorsBDTX
AARD
ABEO
AVTX
CRBU
ENTAStock Performance
Full HistoryAbout Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. is a biotechnology enterprise dedicated to discovering, advancing, and bringing to market therapeutic agents specifically designed for patients with genetically charac…
what is black diamond therapeutics, inc. · bdtx stock overview · black diamond therapeutics, inc. company profile · who is black diamond therapeutics, inc. ceo · bdtx NASDAQ · black diamond therapeutics, inc. headquarters · black diamond therapeutics, inc. business segments
About Stock Overview & Key Data
Black Diamond Therapeutics, Inc. (BDTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 31, 2020. As of the latest trading session, BDTX stock price is $1.85, with a market capitalization of $106.0M. The stock has returned -22.48% over the past 12 months and -20.88% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Black Diamond Therapeutics, Inc. stock is Buy, with an average 12-month price target of $8.00. In fiscal year 2025, Black Diamond Therapeutics, Inc. reported revenue of $70.0M and net income of $22.4M. For detailed data — including Black Diamond Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Black Diamond Therapeutics, Inc. (BDTX) stock price is $1.85. The stock is traded on NASDAQ under the ticker symbol BDTX. The 52-week range is $1.84 – $4.94.